Related Experiment Videos
[Ribozyme targeting as gene therapy method for treatment of malignant tumors]
H Juhl1, F Czubayko, D Henne-Bruns
1Klinik für Allgemeine Chirurgie und Thoraxchirurgie der Christian-Albrechts-Universität, Kiel.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|February 5, 1999
Abstract:
Using HER-2- and pleiotrophin-targeting ribozymes we demonstrated that ribozymes can be used to identify molecules which are highly relevant for tumor growth. Furthermore, ribozymes may be a useful new tool for a highly specific and efficient adjuvant therapy.
Insights
Ribozymes targeting HER-2 and pleiotrophin identified key molecules for tumor growth. These ribozymes show potential as a specific and efficient adjuvant therapy for cancer treatment.
Area of Science:
- Molecular biology
- Biochemistry
- Cancer research
Context:
- Tumorigenesis involves complex molecular pathways.
- Identifying key molecules driving tumor growth is crucial for effective cancer therapy.
- Ribozymes offer precise molecular targeting capabilities.
Purpose:
- To investigate the utility of ribozymes in identifying molecules critical for tumor progression.
- To evaluate the potential of ribozymes as a novel therapeutic strategy in oncology.
Summary:
- Ribozymes designed to target HER-2 (Human Epidermal growth factor Receptor 2) and pleiotrophin were employed.
- The study demonstrated that these ribozymes effectively identified molecules significantly associated with tumor growth.
- This highlights the capability of ribozymes in pinpointing critical factors in tumorigenesis.
Impact:
- Ribozymes can serve as valuable tools for molecular discovery in cancer research.
- The findings suggest that ribozymes hold promise for developing highly specific and efficient adjuvant cancer therapies.